Camino’s Post

🌟 Exciting News: KPI Delta Review Practice at Bayer's GSM Hub Barcelona! 🌟 I’m thrilled to share some insights from the recent KPI Delta Review practice that we’ve successfully implemented at Bayer's GSM Hub in Barcelona. I had the privilege to be involved together with Mari Cruz Puertas by Iza Simunovic in both the creation and implementation of this initiative, and the results have been remarkable! 🔍 Key Takeaways: Data-Driven Decisions: Analyzing KPIs enables us to make informed decisions that truly drive performance. Collaborative Environment: By engaging all team members in the review process, we’ve strengthened our collective accountability and teamwork. Adaptability: This practice empowers us to pivot swiftly in response to our needs. I encourage my colleagues at Bayer and others in our network to explore how similar practices can elevate your teams' performance and inspire innovation. Let’s connect and exchange best practices! 💬 I’d love to hear your thoughts on KPI reviews and how they’ve impacted your work! #KPI #ContinuousImprovement #OperationalExcellence #Networking #Bayer

Read in Pharmafirst magazine

‘Impression share’, ‘share of voice’, ‘coverage’...It's time for Pharma to move beyond awareness metrics that simply create noise 🙉. To influence prescribing decisions and connect with patients, strategic plans and performance metrics matter more than ever. Meet Pippa Short, Medico's Strategy Engagement Lead. With 10+ years in pharma and consumer healthcare. Pippa was recently chosen to represent the PAGB, the consumer healthcare association's 5-year strategy group alongside top life science organisations such as Bayer, Sanofi, Reckitt, Viatris and Haleon. As our Strategy Lead, Pippa identifies connections between trends and client needs, addressing key marketing and communications challenges. If you need sharper digital strategies and analytics to unlock real performance for your products, get in touch. It’s time to tune out the noise and focus on strategic value. #pharmamarketing #strategy #digitalhealth #performance

Do perceptions drive value? We’re glad you asked.   /prompt.'s CEO, Paul Dyer, took the stage at last week's Fierce Pharma PR & Communications Summit West annual summit in an electrifying keynote on how reputation, innovation, and leadership shape investor perceptions. 🌟 Follow our agency pages to learn more on how we're re-shaping the next generation of marketing. ➡ Lippe Taylor twelvenote agency #FiercePharmaPR #communications #pharma #FierceEvents

Sally Susman, Pfizer's Chief Corporate Affairs Officer and author of "Breaking Through," joined Flagship Chief Communications Officer and Executive Partner, Christine Heenan, for a wide ranging #FlagshipDialogues discussion about what it was like to oversee communications as Pfizer was developing and delivering its COVID vaccine, the highs and lows of her career, and captivating insights about leadership and life. Watch the full conversation here: https://lnkd.in/g95V3csn

Trust is crucial in any industry, but for public relations leaders in biopharma, it's a top priority. Despite a slight increase in trust during the COVID-19 pandemic, the pharmaceutical sector remains the least trusted within healthcare, as reported by the Edelman Trust Barometer. This challenge is compounded by the spread of fake news and the rising demand for corporate social advocacy. Hear from industry leaders Angela Dwyer - Fullintel, Jane Woo - AbbVie, Ed Harnaga - Pfizer, Geoff Curtis - Marshall Curtis Communications & Anthony Farina - CSL as they explore strategies for building trust in biopharma, grounded in the latest research findings. They'll cover proven methods to enhance trust and align with your brand's goals. Attendees will learn how to refine messaging strategies, measure impact, and foster enduring trust with stakeholders. Join us at the Fierce Pharma PR & Communications Summit, July 8-9 in Jersey City, NJ to gain the best strategies for cultivating trust within the biopharma industry. Early Bird Ending Today– Save $500! Don't miss out on this opportunity to learn from industry leaders and enhance your company's strategic advantage. Register by June 17th and Save $200! Don’t wait! 👉 https://ow.ly/8r8M50RJPPJ Stay Updated on all our events by following Fierce Life Sciences Events #FiercePharmaPR #WeAreFierce #publicrelations #pharmaceuticals #communications #pharma #FierceEvents #fiercepharma

Is there such a thing as a flawless launch? Can we truly anticipate and mitigate all potential scenarios despite extensive pre-planning that could sometime span years? How to make the perfect trade-offs? How to achieve quick wins while embracing the concept of failing faster with a mixture of agility, openness, and resilience? My journey has afforded me the opportunity to lead both global and regional launches, offering a diverse array of insights. In this intricate process, crafting a message that resonates with Key Opinion Leaders (KOLs) emphasizing the benefits for patients, serve as the crucial entry point. Incentivizing the core launch team and continuous alignment with secondary and tertiary stakeholders are paramount.

How to create Leaders has been Rajiv’s strength and once you meet you him he gives you new ideas to improve upon.

It has been a year since I became CCO for Astellas and given how regularly I am asked what that involves, it feels only right that I try and explain more about my role. With responsibility for the P&L from our Commercial operations, my job may appear to be all about the numbers when, in actual fact, it is more about the people. First and foremost, our patients. It is my job to make sure we bring our innovative medicines to customers, so they can optimally treat and bring value to patients’ lives. But to deliver on that promise takes vision and cohesion, which is why the lion’s share of my internal focus this year has been on building a high-performing, cross-functional team. The success of the Growth Strategy – which identified how we could potentially impact the lives of over nine million more patients – has exceeded all expectations and been a major highlight of the past year. But, of course, Commercial is only one part of a much bigger whole.    Bringing breakthrough discoveries to patients relies on collaboration and partnerships with stakeholders right across the healthcare ecosystem. This is why I value and devote so much time to engaging with healthcare experts, patient groups, government agencies, media and, through my board membership of EFPIA, industry peers: to ensure we support patient access and bring the greatest possible benefit to the lives of our patients globally.    Regular touchpoints with our valued investor community to keep them appraised of the future trajectory and evolution of our business is another vital and fulfilling aspect of my work.    Every conversation reveals something new and inspires me to keep pushing, driving and aspiring for more. Being Astellas CCO is a privilege and I intend to continue extracting every last drop of potential out of every single day!  

🎙 In-Depth Interview with Pharma Media Leader Dr. Susan Dorfman: Our CEO, Richard Springham, recently spoke in depth with Dr. Susan Dorfman, the Global CEO of CMI Media Group. In the course of the conversation, they dived deep into: 🛣 Susan’s journey into pharma media  💡 Advice for professionals in the industry   📈 The evolution of pharma media over the years  🔮 A glimpse into the media agency of 2030  💰 The strategic balance between creative and media budgets globally  🌍 Why ex-US international markets are crucial to CMI 🎥 Watch the full interview here - https://lnkd.in/erNDUW29 #solli #solliglobal #globalpharmamedia #susandorfman #cmi